About: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1985

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1985 (uk) im Juli 1985 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1985 (ast) scientific article published on 01 July 1985 (en)
publication date	wds:Q69899068-1D3F0BAC-3F82-45D5-B579-496BF8616535
publication date	1985-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q69899068-0BA71FFB-670F-4E89-8BC5-AA61C3F673BB wds:Q69899068-0C2521A0-2DB2-4D7B-9399-4FC9A1E7EAD2 wds:Q69899068-1111A0E9-4958-435C-9599-2C449D0E0AC2 wds:Q69899068-26F8AEFF-4A3F-4736-A437-078353D91611 wds:Q69899068-30C834AA-F7B5-4BC9-BBB6-369A99CB4C59 wds:Q69899068-48E50EAC-E431-4083-B9B7-F671D0701421 wds:Q69899068-4AF7F697-F8D9-4C15-8B9B-5E900E1430A7 wds:Q69899068-7629F40A-E38D-4466-882A-E05C6F46E751 wds:Q69899068-AC6BACED-E22A-4947-86B6-8F221DDB9046
author name string	H J Williams R F Willkens C Yarboro C O Samuelson R P Polisson M Guttadauria M E Luggen S R Weiner L M Billingsley
rdfs:label	Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial (en) Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial (nl)
skos:prefLabel	Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial (en) Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial (nl)
name	Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial (en) Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial (nl)
author	wds:Q69899068-3FEB4147-FF6E-448B-90D9-0FA550285B9D
author	Graciela S Alarcón
title	wds:Q69899068-EE53B95D-3D47-4F9B-B3E1-2CD6F1985D0B
title	Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial (en)
page(s)	wds:Q69899068-152B4E44-3A4F-4CD7-9A1B-53CC2E9299F7
page(s)	721-730
instance of	wds:Q69899068-32E2EE08-EE76-4988-B53D-7AB7170D2682
instance of	scholarly article
main subject	wds:Q69899068-14F936C4-9531-4712-B06A-51887647CE7C wds:Q69899068-70498757-58F7-4ECA-898D-EBE19EB76163 wds:Q69899068-B78A3090-1A43-41E1-94F2-00C864FF7FFB
main subject	rheumatoid arthritis placebo wd:Q422232
PubMed ID	wds:Q69899068-A811464F-AE2A-47BB-BE0A-C9DA54FE2A9C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3893441
PubMed ID	3893441
published in	wds:Q69899068-295DFF2D-7F1B-4E24-94E5-C4D0684191E1
published in	Arthritis and Rheumatism
issue	wds:Q69899068-C7A0D45E-B675-4A11-890F-9B075145E1DA
volume	wds:Q69899068-BE07C107-50B7-4EFB-9C7E-91A457763A6D
issue	7
volume	28
DOI	wds:Q69899068-498B8640-CB81-40BA-B93F-456C13EF194C
DOI	http://dx.doi.org/10.1002/ART.1780280702
DOI	10.1002/ART.1780280702
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69899068
is cites work of	The levels of memory (CD45RA-, RO+) CD4+ and CD8+ peripheral blood T-lymphocytes correlate with IgM rheumatoid factors in rheumatoid arthritis. Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells Comparative responsiveness of generic and specific quality-of-life instruments Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis Low-dose oral methotrexate in refractory inflammatory bowel disease Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity Flow cytometric characterisation of the "false naive" (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis. Dietary n-3 fatty acids and therapy for rheumatoid arthritis A clinical approach to the use of methotrexate for sarcoidosis "Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. The treatment of rheumatoid arthritis Mechanisms of action of methotrexate. Disease-modifying antirheumatic drugs. Potential effects in older patients Oral effects of low-dose methotrexate treatment Methotrexate increases expression of cell cycle checkpoint genes via JNK activation Methotrexate therapy in rheumatoid arthritis. Current status Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK. Going with the flow: methotrexate, adenosine, and blood flow Controlled trial of methotrexate versus 10-deazaaminopterin in the treatment of rheumatoid arthritis Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritis Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis? Methotrexate for treating rheumatoid arthritis The effect of methylprednisolone pulse therapy on methotrexate treatment of rheumatoid arthritis Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight–week randomized, double-blind trial Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis Psychological control and its impact in the management of rheumatological disorders Methotrexate in rheumatoid arthritis: a quarter century of development Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study). Adenosine in inflammatory joint diseases. The place of methotrexate perioperatively in elective orthopedic surgeries in patients with rheumatoid arthritis Rheumatoid arthritis in 2003: where are we now with treatment? Rational use of disease-modifying antirheumatic drugs Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures Comparison of the efficacy of the tumour necrosis factor blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis Early rheumatoid arthritis: pitfalls in diagnosis and review of recent clinical trials

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software